Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

It's Class I For Recall Of Smiths Medical Insulin Syringes, FDA Says

Executive Summary

Certain models and lots of Jelco Hypodermic Needle-Pro Fixed Needle Insulin Syringes were recalled on 16 June because they “may exhibit skewed odd number line graduation markings on their syringe barrels.”

You may also be interested in...



More Headaches For Philips As FDA Labels Another Ventilator Recall As High-Risk Class I

The recalled vents are designed to provide high-flow therapy to patients, but problems can crop up “if the system pressure reaches the default maximum limit,” the US agency says. The recall is more bad news for Philips, which recently initiated a separate class I recall of certain breathing and ventilator devices.

New FDA Webform Makes It Easier For Device Makers To Report Shortages

The US agency on 3 August said the webform should be used by manufacturers to report shortages of products deemed critical to fighting the ongoing COVID-19 pandemic.

DOJ: Alere Unit Billed Medicare For Diabetic Testing Supplies For The Dead

Alere Medical and its now-defunct subsidiary Arriva Medical will pay the US government $160m to settle allegations that they violated the False Claims Act. It’s the second settlement that Alere has entered into with the Department of Justice in recent weeks.

Topics

UsernamePublicRestriction

Register

MT144097

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel